Search results
Author(s):
Johanna McChord
,
Astrid Hubert
,
Udo Sechtem
,
et al
Added:
6 months ago
Author(s):
Rasha Al-Lamee
,
Christopher Rajkumar
,
Nazli Okumus
Added:
1 year ago
AHA 2023 — Investigators of ORBITA-2 trial, Dr Rasha Al-Lamee and Dr Christopher Rajkumar (Imperial College London, UK) talked with CardioNerds Ambassador, Dr Nazli Okumus about the randomised, placebo-controlled trial (NCT03742050) that compared the effects of coronary angioplasty versus placebo procedure on symptoms of stable angina without background anti-anginal therapy at 12 weeks.The ORBITA…
View more
Author(s):
Rasha Al-Lamee
,
Michael Foley
Added:
1 year ago
ACC.24 — Investigators, Dr Rasha K Al-Lamee and Dr Michael Foley (Imperial College London, UK) joined us to discuss the ORBITA COSMIC trial (NCT04892537).This randomized, double-blinded, placebo-controlled trial investigated the effects of coronary sinus reducer (CSR) as compared to placebo on myocardial perfusion via MRI, exercise duration, and symptoms in patients with refractory angina and…
View more
Author(s):
John F Beltrame
,
Peter Ong
,
Filippo Crea
Added:
1 year ago
Author(s):
Juan Carlos Kaski
,
Hiroaki Shimokawa
Added:
1 year ago
Eva Prescott
Research Area(s) / Expertise:
Job title: Professor at Bispebjerg Hospital, Department of Cardiology, Copenhagen, Denmark
Author
Juan Carlos Kaski
Research Area(s) / Expertise:
Author
Expertise
Prevention & Chronic ConditionsHeart FailureAnginaCoronary Artery DiseaseElectrophysiology & ArrhythmiaHypertensionGuidelines & StatementsImaging & DiagnosticsMI/ACSUnstable Angina & NSTEMIAtherosclerosis and HyperlipidemiaDiabetesEthnicityAtrial FibrillationDemographicInterventionAtrial ArrhythmiasCV Disease in Special PopulationsCoronary InterventionsVascular Disease and SurgeryCoronary PhysiologyCarotid Artery Disease
Author(s):
William E Boden
,
Juan Carlos Kaski
,
C Noel Bairey Merz
,
et al
Added:
2 weeks ago
Author(s):
Gaetano Antonio Lanza
,
Hiroaki Shimokawa
Added:
1 year ago